These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36810721)

  • 1. IRF2BPL: A new genotype for progressive myoclonus epilepsies.
    Costa C; Oliver KL; Calvello C; Cameron JM; Imperatore V; Tonelli L; Colavito D; Franceschetti S; Canafoglia L; Berkovic SF; Prontera P
    Epilepsia; 2023 Aug; 64(8):e164-e169. PubMed ID: 36810721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF2BPL as a novel causative gene for progressive myoclonus epilepsy.
    Gardella E; Michelucci R; Christensen HM; Fenger CD; Reale C; Riguzzi P; Pasini E; Albini-Riccioli L; Papa V; Foschini MP; Cenacchi G; Furia F; Marjanovic D; Hammer TB; Møller RS; Rubboli G
    Epilepsia; 2023 Aug; 64(8):e170-e176. PubMed ID: 37114479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy.
    Tran Mau-Them F; Guibaud L; Duplomb L; Keren B; Lindstrom K; Marey I; Mochel F; van den Boogaard MJ; Oegema R; Nava C; Masurel A; Jouan T; Jansen FE; Au M; Chen AH; Cho M; Duffourd Y; Lozier E; Konovalov F; Sharkov A; Korostelev S; Urteaga B; Dickson P; Vera M; Martínez-Agosto JA; Begemann A; Zweier M; Schmitt-Mechelke T; Rauch A; Philippe C; van Gassen K; Nelson S; Graham JM; Friedman J; Faivre L; Lin HJ; Thauvin-Robinet C; Vitobello A
    Genet Med; 2019 Apr; 21(4):1008-1014. PubMed ID: 30166628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes.
    Courage C; Oliver KL; Park EJ; Cameron JM; Grabińska KA; Muona M; Canafoglia L; Gambardella A; Said E; Afawi Z; Baykan B; Brandt C; di Bonaventura C; Chew HB; Criscuolo C; Dibbens LM; Castellotti B; Riguzzi P; Labate A; Filla A; Giallonardo AT; Berecki G; Jackson CB; Joensuu T; Damiano JA; Kivity S; Korczyn A; Palotie A; Striano P; Uccellini D; Giuliano L; Andermann E; Scheffer IE; Michelucci R; Bahlo M; Franceschetti S; Sessa WC; Berkovic SF; Lehesjoki AE
    Am J Hum Genet; 2021 Apr; 108(4):722-738. PubMed ID: 33798445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRF2BPL gene variants with dystonia: one new Chinese case report.
    Yang F; Li H; Dai Y; Zhang R; Zhang JT
    BMC Neurol; 2023 Jan; 23(1):32. PubMed ID: 36670390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenic gene variants and clinical phenotype features of 26 children with progressive myoclonic epilepsy].
    Zhang J; Zhang YH; Chen JY; Ji TY; Yang ZX; Yang XL; Sun W; Zhang LP; Wu XR
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):458-464. PubMed ID: 31216804
    [No Abstract]   [Full Text] [Related]  

  • 7. Progressive myoclonus epilepsies due to SEMA6B mutations. New variants and appraisal of published phenotypes.
    Castellotti B; Canafoglia L; Freri E; Tappatà M; Messina G; Magri S; DiFrancesco JC; Fanella M; Di Bonaventura C; Morano A; Granata T; Gellera C; Franceschetti S; Michelucci R
    Epilepsia Open; 2023 Jun; 8(2):645-650. PubMed ID: 36719163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of IRF2BPL in a Taiwanese dystonia cohort: The genotype and phenotype correlation.
    Chen PS; Chen YF; Chiu JY; Wu MC; Tai CH; Chang YY; Lan MY; Lee NC; Lin CH
    Ann Clin Transl Neurol; 2024 Jun; 11(6):1557-1566. PubMed ID: 38650104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental disorder caused by a truncating de novo variant of IRF2BPL.
    Qian XH; Liu XY; Zhu ZY; Wang SG; Song XX; Chen G; Wu JY; Tang HD; Cao L
    Seizure; 2021 Jan; 84():47-52. PubMed ID: 33278788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of familial adult myoclonic epilepsy.
    Baykan B; Franceschetti S; Canafoglia L; Cavalleri GL; Michelucci R; Scheffer IE
    Epilepsia; 2023 Jun; 64 Suppl 1():S52-S57. PubMed ID: 36751956
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Heide S; Davoine CS; Cunha P; Scherer-Gagou C; Keren B; Stevanin G; Charles P; Heron D; Brice A; Durr A
    Neurol Genet; 2023 Dec; 9(6):e200096. PubMed ID: 38235039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole exome sequencing identifies variable expressivity of CLN6 variants in Progressive myoclonic epilepsy affected families.
    Ilyas M; Tariq F; Ishaq R; Habiba U; Bibi F; Khan SN; Ali Y; Haider S; Efthymiou S; Abdullah U; Raja GK; Shaiq PA
    Epilepsy Res; 2024 Mar; 201():107283. PubMed ID: 38382230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCTD7-related progressive myoclonic epilepsy: Report of 42 cases and review of literature.
    Yoganathan S; Whitney R; Thomas M; Danda S; Chettali AM; Prasad AN; Farhan SMK; AlSowat D; Abukhaled M; Aldhalaan H; Gowda VK; Kinhal UV; Bylappa AY; Konanki R; Lingappa L; Parchuri BM; Appendino JP; Scantlebury MH; Cunningham J; Hadjinicolaou A; El Achkar CM; Kamate M; Menon RN; Jose M; Riordan G; Kannan L; Jain V; Manokaran RK; Chau V; Donner EJ; Costain G; Minassian BA; Jain P
    Epilepsia; 2024 Mar; 65(3):709-724. PubMed ID: 38231304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo variants of IRF2BPL result in developmental epileptic disorder.
    Wang Y; Ke Z; Li Y; Qiu M; Liu J; Yang Z; Wen S; Liang M; Chen S
    Orphanet J Rare Dis; 2024 Mar; 19(1):121. PubMed ID: 38481258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel missense variant in the LMNB2 gene causes progressive myoclonus epilepsy.
    Soleimanipour F; Razmara E; Rahbarizadeh F; Fallahi E; Khodaeian M; Tavasoli AR; Garshasbi M
    Acta Neurol Belg; 2022 Jun; 122(3):659-667. PubMed ID: 33783721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De Novo Truncating Variants in the Last Exon of SEMA6B Cause Progressive Myoclonic Epilepsy.
    Hamanaka K; Imagawa E; Koshimizu E; Miyatake S; Tohyama J; Yamagata T; Miyauchi A; Ekhilevitch N; Nakamura F; Kawashima T; Goshima Y; Mohamed AR; Ch'ng GS; Fujita A; Azuma Y; Yasuda K; Imamura S; Nakashima M; Saitsu H; Mitsuhashi S; Mizuguchi T; Takata A; Miyake N; Matsumoto N
    Am J Hum Genet; 2020 Apr; 106(4):549-558. PubMed ID: 32169168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial cases of progressive myoclonic epilepsy caused by maternal somatic mosaicism of a recurrent KCNC1 p.Arg320His mutation.
    Kim H; Lee S; Choi M; Kim H; Hwang H; Choi J; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2018 May; 40(5):429-432. PubMed ID: 29428275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myoclonus and epilepsies in children].
    Fejerman N
    Rev Neurol (Paris); 1991; 147(12):782-97. PubMed ID: 1780607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
    Muona M; Berkovic SF; Dibbens LM; Oliver KL; Maljevic S; Bayly MA; Joensuu T; Canafoglia L; Franceschetti S; Michelucci R; Markkinen S; Heron SE; Hildebrand MS; Andermann E; Andermann F; Gambardella A; Tinuper P; Licchetta L; Scheffer IE; Criscuolo C; Filla A; Ferlazzo E; Ahmad J; Ahmad A; Baykan B; Said E; Topcu M; Riguzzi P; King MD; Ozkara C; Andrade DM; Engelsen BA; Crespel A; Lindenau M; Lohmann E; Saletti V; Massano J; Privitera M; Espay AJ; Kauffmann B; Duchowny M; Møller RS; Straussberg R; Afawi Z; Ben-Zeev B; Samocha KE; Daly MJ; Petrou S; Lerche H; Palotie A; Lehesjoki AE
    Nat Genet; 2015 Jan; 47(1):39-46. PubMed ID: 25401298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular genetic bases of the progressive myoclonus epilepsies.
    Serratosa JM; Gardiner RM; Lehesjoki AE; Pennacchio LA; Myers RM
    Adv Neurol; 1999; 79():383-98. PubMed ID: 10514828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.